The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis

Viral Immunology

Volumn 25, Issue 2, 2012, Pages 161-165

  Aghamohammadi, Asghar ^a   Abolhassani, Hassan ^a   Hirbod Mobarakeh, Armin ^a   Ghassemi, Fariba ^b   Shahinpour, Shervin ^a   Behniafard, Nasrin ^a   Naghibzadeh, Ghazal ^a   Imanzadeh, Amir ^a   Rezaei, Nima ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETAMETHASONE; CHLORAMPHENICOL; CYCLOPLEGIC AGENT; GANCICLOVIR; IMMUNOGLOBULIN;

ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CELLULAR IMMUNITY; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; COMORBIDITY; CYTOMEGALOVIRUS RETINITIS; DISEASE SEVERITY; FOLLOW UP; GRANULOMATOUS INFLAMMATION; GYNECOMASTIA; HUMAN; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION SYNDROME; MALE; PANCYTOPENIA; PHENOTYPE; PRESCHOOL CHILD; RETINA DETACHMENT; SCHOOL CHILD; SPLENOMEGALY; UMBILICAL HERNIA; VISUAL IMPAIRMENT;

CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; CYTOMEGALOVIRUS RETINITIS; HUMANS; INFANT; INFANT, NEWBORN; MACROPHAGE ACTIVATION SYNDROME; MALE;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS;

EID: 84859618051     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0060     Document Type: Article

References (37)

1. Chapel H, and Cunningham-Rundles C: Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145:709-727.
2. Aghamohammadi A, Parvaneh N, and Rezaei N: Common variable immunodeficiency: A heterogeneous group needs further subclassification. Expert Rev Clin Immunol 2009;5: 629-631.
3. Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, and Rezaei N: Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol 2010;20:372-379.
4. Aghamohammadi A, Farhoudi A, Moin M, et al.: Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12:825-832. (Pubitemid 40993281)
5. Aghamohammadi A, Parvaneh N, Tirgari F, et al.: Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 2006;47:343-346. (Pubitemid 43084578)
6. Aghamohammadi A, Allahverdi A, Abolhassani H, et al.: Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010;15:289-295.
7. Khodadad A, Aghamohammadi A, Parvaneh N, et al.: Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52:2977-2983. (Pubitemid 47512541)
8. Rezaei N, Aghamohammadi A, Kardar GA, Nourizadeh M, and Pourpak Z: T-helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2008;18:449-453.
9. Rezaei N, Aghamohammadi A, Nourizadeh M, et al.: Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol 2010; 20:244-251.
10. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, and Aghamohammadi A: Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009;155:21-27.
11. Rezaei N, Haji-Molla-Hoseini M, Aghamohammadi A, Pourfathollah AA, Moghtadaie M, and Pourpak Z: Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol 2008;28:78-84.
12. Rezaei N, Wing JB, Aghamohammadi A, et al.: B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum Immunol 2010;71:355-362.
13. Rezaei N, Aghamohammadi A, Siadat SD, et al.: Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol 2008;15:607-611. (Pubitemid 351967054)
14. Abolhassani H, Aghamohammadi A, Abolhassani F, Eftekhar H, Heidarnia M, and Rezaei N: Health policy for common variable immunodeficiency: Burden of the disease. J Investig Allergol Clin Immunol 2011;21:454-458.
15. Rezaei N, Abolhassani H, Aghamohammadi A, and Ochs HD: Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol 2011; 7:301-316.
16. Chapel H, Lucas M, Lee M, et al.: Common variable immunodeficiency disorders: Division into distinct clinical phenotypes. Blood 2008;112:277-286.
17. Cunningham-Rundles C: Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008; 28(Suppl 1):S42-S45.
18. Giannouli S, Anagnostou D, Soliotis F, and Voulgarelis M: Autoimmune manifestations in common variable immunodeficiency. Clin Rheumatol 2004;23:449-452. (Pubitemid 39386443)
19. Sissons JG, and Carmichael AJ: Clinical aspects and management of cytomegalovirus infection. J Infect 2002;44:78-83. (Pubitemid 34785345)
20. Fallah S, Tabatabaei A, Pournasir Z, Chavoshzadeh Z, and Rezaei N: Cutaneous cytomegalovirus infection in a child with hyper IgE and specific defects in antibody response to protein vaccines. Braz J Infect Dis 2011;15:484-485.
21. Daugherty WP, Clarke MJ, Cloft HJ, and Lanzino GL: Going viral: Fusiform vertebrobasilar and internal carotid aneurysms with varicella angiitis and common variable immunodeficiency. J Neurosurg Pediatr 2009;4:528-531.
22. Haveman LM, Scherrenburg J, Maarschalk-Ellerbroek LJ, et al.: T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency. Clin Exp Immunol 2010;161:108-117.
23. Modlin JF: Update on enterovirus infections in infants and children. Adv Pediatr Infect Dis 1996;12:155-180.
24. Stack E, Washington K, Avant GR, and Eisen GM: Cytomegalovirus enteritis in common variable immunodeficiency. South Med J 2004;97:96-101. (Pubitemid 38112487)
25. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, and Falagas ME: Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review. Virol J 2008;5:47.
26. Mullighan CG, Read SJ, Bird AG, Kurtz JB, Chapel HM, and Welsh KI: Human cytomegalovirus infection is not increased in common variable immunodeficiency. J Clin Immunol 1996;16:272-277. (Pubitemid 26338201)
27. van Spronsen DJ, and Breed WP: Cytomegalovirus-induced thrombocytopenia and haemolysis in an immunocompetent adult. Br J Haematol 1996;92:218-220. (Pubitemid 26018790)
28. Ichiche M, Fontaine C, and Lacor P: Severe thrombocytopenia secondary to cytomegalovirus infection in an immunocompetent adult. Eur J Intern Med 2003;14:56-59. (Pubitemid 36120570)
29. Close P, Friedman D, and Uri A: Viral-associated hemophagocytic syndrome. Med Pediatr Oncol 1990;18:119-122. (Pubitemid 20096347)
30. Teich SA, Orellana J, and Friedman AH: Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol 1987;104:312-314.
31. Spaide RF, Gaissinger A, and Podhorzer JR: Risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection. Ophthalmology 1995;102:1860-1864. (Pubitemid 26004441)
32. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, and Tonascia JA: Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 2003;121:466-476. (Pubitemid 36427633)
33. Thorne JE, Van Natta ML, Jabs DA, Duncan JL, and Srivastava SK: Visual field loss in patients with cytomegalovirus retinitis. Ophthalmology 2011;118:895-901.
34. Gandhi MK, and Khanna R: Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004;4:725-738. (Pubitemid 39574344)
35. Studahl M, Bergstrom T, Ekeland-Sjoberg K, and Ricksten A: Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection. J Med Virol 1995;46:274-280.
36. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. N Engl J Med 1992;326:213-220.
37. Banker AS: Posterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol 2008;56:377-383.